Solid Biosciences Inc. (SLDB) Revenue History
Annual and quarterly revenue from 2015 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SLDB Revenue Growth
SLDB Revenue Analysis (2015–2025)
As of May 8, 2026, Solid Biosciences Inc. (SLDB) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, SLDB's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $13.6 million in 2021.
When compared to Healthcare sector peers including SRPT (-2.2% YoY), CRSP (-88.9% YoY), and SGMO (-37.1% YoY). Compare SLDB vs SRPT →
SLDB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SLDBCurrent | $0 | - | - | - | |
 SRPT | $2.2B | -2.2% | +32.4% | -29.9% | |
 CRSP | $4M | -88.9% | +37.3% | -16191.4% | |
 SGMO | $58M | -37.1% | -10.8% | -179.9% | |
 FOLD | $634M | +20.0% | +19.4% | 5.4% |
SLDB Historical Revenue Data (2015–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-179,206,000 | - |
| 2024 | $0 | - | $-2,455,000 | - | $-129,728,000 | - |
| 2023 | $0 | -100.0% | $-2,581,000 | - | $-104,315,000 | - |
| 2022 | $8.1M | -40.6% | $8.1M | 100.0% | $-106,452,000 | -1315.2% |
| 2021 | $13.6M | - | $13.6M | 100.0% | $-72,254,000 | -530.5% |
| 2020 | $0 | - | $-3,922,000 | - | $-86,462,000 | - |
| 2019 | $0 | - | $-2,824,000 | - | $-119,318,000 | - |
| 2018 | $0 | - | $-1,566,000 | - | $-75,687,000 | - |
| 2017 | $0 | - | $-448,000 | - | $-54,857,000 | - |
| 2016 | $0 | - | $-56,000 | - | $-25,576,000 | - |
See SLDB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SLDB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SLDB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSLDB — Frequently Asked Questions
Quick answers to the most common questions about buying SLDB stock.
Is SLDB's revenue growth accelerating or slowing?
SLDB TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is SLDB's long-term revenue growth rate?
Solid Biosciences Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is SLDB's revenue distributed by segment?
SLDB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2015-2025 are available for download. Segment mix reveals concentration and diversification trends.